Peking University Shenzhen Hospital

Hepatobiliary and Pancreatic Surgery

I. Department Introduction: The Department of Hepatobiliary and Pancreatic Surgery of Peking University Shenzhen Hospital is one of the most comprehensive and strongest treatment centers for hepatobiliary and pancreatic diseases in Shenzhen. Since its establishment in 2005, the department has consistently adhered to treatment concepts that keep pace with the times and pursued excellence in medical technology, supplemented by the meticulous humanistic care of its nursing team, to provide patients with high-quality, cutting-edge medical services. At present, the department has 67 approved beds and an independent endoscopy unit. The medical team consists of 8 chief physicians, 3 associate chief physicians, 5 attending physicians, and 2 resident physicians. It performs more than 2,000 operations annually, with professional coverage of all difficult and complex diseases in hepatobiliary and pancreatic surgery, including hepatobiliary and pancreatic tumors, cholelithiasis, and abdominal wall hernias, making it a key medical force safeguarding the surgical health of people in Shenzhen and surrounding areas. II. Department Honors: Guangdong Provincial Key Clinical Specialty Standing Council Member Institution of the Guangdong ERCP Alliance Member Institution of the Guangdong Pancreatic Minimally Invasive Diagnosis and Treatment Alliance Institution Introducing the Team of Academician Chen Xiaoping under the “Three Famous Medical and Health Professionals Project” of the Shenzhen Municipal Health and Family Planning Commission Academician Chen Xiaoping Workstation under the “Three Famous Medical and Health Professionals Project” of the Shenzhen Municipal Health and Family Planning Commission Chinese Branch of the International Hepato-Pancreato-Biliary Association and China Hepatobiliary and Pancreatic Specialty Alliance Remote Medical Demonstration Center of the Chinese Branch of the International Hepato-Pancreato-Biliary Association Multidisciplinary Comprehensive Treatment Demonstration Institution of the Chinese Branch of the International Hepato-Pancreato-Biliary Association Biliary Stone Diagnosis and Treatment Center of Peking University Shenzhen Hospital Minimally Invasive and Non-invasive Surgery Demonstration Center of Peking University Shenzhen Hospital Standardized Training Base for Specialists of Peking University III. Scope of Diagnosis and Treatment: Pancreatic tumors, liver tumors, hepatic cysts and hemangiomas, malignant biliary tumors, cholelithiasis, cholecystitis and gallbladder polyps, abdominal wall hernias, severe acute pancreatitis, targeted immunotherapy for malignant tumors IV. Technical Expertise: Minimally invasive surgery for pancreatic tumors, minimally invasive treatment of liver tumors, radical resection of hilar cholangiocarcinoma, endoscopic retrograde cholangiopancreatography (ERCP), minimally invasive cholecystectomy and biliary reconstruction, management of complex cholelithiasis, minimally invasive hernia surgery, 3D laparoscopic and robotic surgery, comprehensive treatment of severe acute pancreatitis, extensive hepatectomy, combined multiorgan resection for malignant tumors V. Department Advantages: 1. Minimally Invasive Surgery for Hepatobiliary and Pancreatic Tumors The Hepatobiliary and Pancreatic Surgery Department of Peking University Shenzhen Hospital closely follows the forefront of minimally invasive surgical technology development and focuses on continuously advancing surgical techniques for hepatobiliary and pancreatic tumors. At present, the department routinely performs advanced minimally invasive procedures, including 3D laparoscopy, 4K high-definition laparoscopy, and fluorescence microscopy. It has completed high-difficulty hepatobiliary and pancreatic surgical procedures such as laparoscopic pancreaticoduodenectomy (LPD), robot-assisted pancreaticoduodenectomy (RPD), and laparoscopic anatomical liver resection (LALR), with an annual surgical volume of more than 400 procedures, covering various laparoscopic radical tumor resections. These technologies and devices not only greatly improve surgical clarity and precision, thereby increasing the radical resection rate, but also significantly reduce surgical trauma and shorten patients’ postoperative recovery time. 2. Minimally Invasive Treatment Center for Cholelithiasis The department is committed to providing individualized comprehensive treatment for gallbladder and bile duct stones, offering patients efficient and safe treatment plans. At present, the annual surgical volume has reached 1,600 procedures. Single-incision laparoscopic surgery and natural orifice transluminal endoscopic surgery (NOTES) have also been introduced into clinical practice, providing patients with more minimally invasive treatment options. The department is equipped with an independent endoscopy unit and has introduced high-tech equipment, including electronic duodenoscopes, mother-baby endoscopes, electronic choledochoscopes, and low-temperature electrosurgical knives. More than 200 ERCP procedures are performed annually. The treatment of patients with complex biliary stones complicated by cholangitis and biliary stricture using biliary stents and biliary drainage is at the national leading level. 3. Conversion Therapy for Advanced Tumors Conversion therapy plays a crucial role in the treatment of advanced tumors. The department adopts a multidisciplinary team (MDT) discussion model, bringing together top experts in oncology, surgery, radiology, and pathology to formulate individualized treatment plans for each patient. Through MDT discussions, we ensure that every case receives a comprehensive assessment and optimal treatment recommendations from different professional perspectives. Through chemotherapy, radiotherapy, targeted therapy, immunotherapy, and other treatments, unresectable tumors can be converted into tumors amenable to R0 resection, prolonging progression-free survival and overall survival and improving quality of life. At present, our department’s tumor conversion therapy has reached internationally advanced standards. Through scientifically rigorous treatment methods and close teamwork, it brings every patient hope and the possibility of recovery. 4. Enhanced Recovery After Surgery Professional Group Under the guidance of the enhanced recovery after surgery (ERAS) concept, the department comprehensively applies anesthesia management, minimally invasive techniques, nutritional support, pain control, and other measures to ensure that patients are fully prepared before surgery, surgical trauma is minimized during surgery, and recovery is rapid after surgery. The department has a professional team composed of experienced surgeons, anesthesiologists, nurses, and rehabilitation therapists. It fully leverages the advantages of multidisciplinary collaboration to provide patients with a faster and safer postoperative recovery experience. Through multidisciplinary collaboration and individualized treatment plans, it significantly shortens hospital stays, reduces postoperative complications, and improves patients’ quality of life. VI. Technical Equipment: 1. 3D Fluorescence Laparoscope The 3D fluorescence laparoscope combines 3D imaging technology with fluorescence imaging technology, enabling surgeons to obtain clearer and more three-dimensional visual effects during surgery. 3D imaging captures images through dual lenses, providing physicians with a true stereoscopic view and helping improve surgical precision and safety. Fluorescence imaging uses specific wavelengths and fluorescent dyes to label lesions or important structures, allowing them to be precisely visualized intraoperatively. This technology greatly improves the success rate of surgery and patients’ postoperative recovery in high-difficulty procedures such as complex cancer resection, lymph node dissection, and vascular anatomy. 2. da Vinci Robot-Assisted Surgery da Vinci robot-assisted hepatobiliary and pancreatic surgery is a high-tech minimally invasive surgical approach. The high-resolution 3D stereoscopic vision and multi-degree-of-freedom robotic arms equipped in the da Vinci system enable surgeons to precisely remove lesions and suture tissues while reducing damage to surrounding healthy tissues. This technology is particularly suitable for complex resection of hepatobiliary and pancreatic tumors. It helps shorten operative time, reduce intraoperative blood loss, lower the incidence of postoperative complications, and improve patients’ recovery speed and surgical outcomes. 3. Choledochoscopy and Digestive Endoscopy The combined use of ERCP (endoscopic retrograde cholangiopancreatography) and choledochoscopy in the treatment of cholelithiasis offers significant advantages, particularly in the management of complex cases of cholelithiasis. ERCP can provide treatment while performing diagnosis. By inserting the endoscope retrogradely into the bile duct, physicians can directly observe the biliary system and use various instruments to remove stones. Choledochoscopy provides a more direct field of view and greater operating precision, while also enabling further intraoperative examination of the condition inside the bile duct. The combination of the two can provide patients with individualized comprehensive treatment for biliary stones, reduce operative time and postoperative complications, and improve the treatment success rate. VII. Introduction to the Nursing Team The nursing team is an outstanding team with extensive experience and a high level of professional competence. It consists of 27 nursing personnel, including 2 deputy chief nurses, 13 supervising nurses, 8 nurses, and 4 on-the-job accompanying nurses. All team members possess solid professional knowledge and extensive clinical experience, providing patients with comprehensive, high-quality nursing services. The deputy chief nurses lead the team and guide clinical nursing work, while the supervising nurses play a central role in daily nursing care, ensuring that every patient receives meticulous care and attention. Our team is committed to providing the highest-quality patient-centered nursing services and helping patients recover as soon as possible. VIII. Talent Development Structure Following the discipline-development model of teaching hospitals, the department has built a high-level medical innovation platform, strengthened collaboration among medical care, education, and research, introduced medical innovation teams, cultivated innovative talent, and made every effort to build a discipline integrating medical care, education, and research in all respects. At present, all team members have graduated from key medical schools in China or overseas universities. A total of 3 members have been selected for the Shenzhen High-Level Talent Program or the Shenzhen Health and Medical Elite Talent Development Program. Long-term visiting study and training relationships have been established with Jackson Memorial Hospital affiliated with the University of Miami in the United States, Universität Ulm in Germany, Stralsund Hospital of the Northern Germany Hepatobiliary Treatment Center, the Cancer Institute of the Japanese Foundation for Cancer Research, Queen Mary Hospital of The University of Hong Kong, and others. As the first postdoctoral research workstation in Shenzhen’s medical system, Peking University Shenzhen Hospital also undertakes postdoctoral training in hepatobiliary and pancreatic surgery. At the same time, as a specialty discipline of Peking University Shenzhen Hospital, it undertakes clinical master’s training tasks for Peking University, Shenzhen University, Shantou University, Anhui Medical University, and several other universities, training 3–4 graduate students each year. In scientific research, the department focuses on the molecular mechanisms underlying the development of liver cancer and pancreatic cancer and has conducted a series of studies. It has also conducted feasibility studies on pancreatic islet cell transplantation for the treatment of diabetes. The department undertakes 3 National Natural Science Foundation of China projects, 5 provincial- and ministerial-level or higher scientific research projects, and 8 municipal-level scientific research projects; holds 20 national utility patents and 1 invention patent; has received approximately RMB 8 million in scientific research funding; and has published more than 50 SCI papers.